Acoltremon
Brand names: Tryptyr · Active ingredient: Acoltremon
In short: TRYPTYR is indicated for the treatment of the signs and symptoms of dry eye disease.
What is Acoltremon used for?
TRYPTYR is indicated for the treatment of the signs and symptoms of dry eye disease.
Acoltremon dosage
Instill one drop in each eye twice daily (approximately 12 hours apart).
Wash hands before use.
The single-dose vials are to be used immediately after opening and can be used to dose both eyes. Discard the single-dose vial, including any remaining contents, immediately after use.
TRYPTYR can be used concomitantly with other topical ophthalmic eye drops. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.
Contact lenses should be removed prior to the administration of TRYPTYR and may be reinserted 15 minutes following administration.
If one dose is missed, treatment should continue with the next dose.
How to take Acoltremon — instructions & advice from the label
Advise patients to read the FDA-approved patient labeling (Instructions for Use).
Potential for Eye Injury and Contamination
Advise patients not to touch the tip of the single-dose vial to their eye or to any surface in order to avoid eye injury or contamination of the solution .
Advise patients that one single-dose vial can be used to dose both eyes immediately after opening. Discard the single-dose vial, including any remaining contents, after use .
Use With Contact Lenses
Advise patients that contact lenses should be removed prior to administration of TRYPTYR and can be reinserted 15 minutes after administration .
Use with Other Ophthalmic Drugs
Advise patients that if more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart .
Storage Information
Instruct patients to store unopened single-dose vials in the original foil pouch until ready to use .
Manufactured for Alcon Laboratories, Inc. Fort Worth, TX 76134, USA.
U.S. Pat.: www.alconpatents.com
©2025 Alcon Inc.
Warnings & precautions
Do not take this medicine if: None.
To avoid the potential for eye injury and contamination, do not touch the vial tip to the eye or other surfaces.
TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration of TRYPTYR.
Acoltremon side effects
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In patients with dry eye disease, 766 patients received at least one dose of TRYPTYR in four randomized controlled clinical trials across 71 sites in the United States. The most common ocular adverse reaction observed in controlled clinical studies with TRYPTYR was instillation site pain (50%). Less than 1% of patients discontinued therapy due to burning or stinging sensation in the eyes.
About this medicine
TRYPTYR (acoltremon ophthalmic solution) 0.003% contains an agonist of TRPM8 ion channels. Acoltremon’s chemical name is (1R,2S,5R)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-carboxamide. The molecular formula of acoltremon is C18H27NO2 and has a molecular weight of 289.42 g/mol.
Acoltremon is a white to pale yellow crystalline solid, that is insoluble in water.
TRYPTYR is a sterile, clear to slightly opalescent, colorless, isotonic aqueous solution for topical ophthalmic use, with a pH of approximately 7 and an osmolality of 280 to 330 mOsm/kg. Each mL of TRYPTYR contains active: acoltremon 0.003%; and inactives: polyoxyl 35 castor oil, sodium dihydrogen phosphate dihydrate, sodium chloride, hypromellose and purified water. Additionally, sodium hydroxide is used to adjust pH. TRYPTYR does not contain an anti-microbial preservative.
How it works: Studies in animals suggest that acoltremon, the active substance in TRYPTYR, is an agonist of transient receptor potential melastatin 8 (TRPM8) thermoreceptors. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 2b7715a1-035c-4002-b582-5238efee5d58. Read the full official label on DailyMed.